Press release - 02/04/2026 Pocket-sized biomedical technology to become smarter Volkswagen Foundation supports mobile health expert Professor Walter Karlen The Volkswagen Foundation is supporting the Ulm scientist Professor Walter Karlen with more than 940,000 euros from the funding initiative "Momentum - funding for first-time researchers". The engineer has headed the Institute of Biomedical Engineering at Ulm University since 2021. Karlen conducts research in the field of mobile health on so-called Medicine Wearables, i.e. portable technology for recording health data. https://www.gesundheitsindustrie-bw.de/en/article/press-release/pocket-sized-biomedical-technology-become-smarter-volkswagen-foundation-supports-mobile-health-expert-professor-walter-karlen
Press release - 01/04/2026 Digital Assistance System Designed to Prevent Recurrent Heart Disease Women who have experienced a stroke or heart attack are at a higher risk of mortality than men. Fraunhofer researchers want to improve gender-specific aftercare with a customized assistance system – thus helping to prevent further heart disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-assistance-system-designed-prevent-recurrent-heart-disease
Press release - 31/03/2026 First steps towards cell therapy for brain disorders Researchers in Freiburg have found a way to selectively replace defective immune cells in the blood vessels of the brain using an animal model. This is an important first step towards cell therapies for Alzheimer’s disease and other brain disorders. The findings were recently published in the journal Nature Immunology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/first-steps-towards-cell-therapy-brain-disorders
Proof-of-concept study of organoid technology - 26/03/2026 Can organoids improve the treatment of pancreatic cancer? A clinical trial called UNITEPANC is exploring whether organoid-based approaches can improve the treatment of pancreatic cancer. BIOPRO Baden-Württemberg spoke with the study’s principal investigator and pancreatic cancer specialist, Prof. Dr. Thomas Seufferlein of University Hospital Ulm, to discuss the disease more broadly along with the specific aims of the trial. The interview was conducted by Walter Pytlik on behalf of BIOPRO.https://www.gesundheitsindustrie-bw.de/en/article/news/can-organoids-improve-treatment-pancreatic-cancer
Press release - 25/03/2026 The Influence of Lymph Node Architecture on Lymphoma For the first time, researchers have succeeded in mapping the organization of immune cells in human lymph nodes. The study was led by scientists from Heinrich Heine University Düsseldorf, Düsseldorf University Hospital, the DKFZ, the European Molecular Biology Laboratory (EMBL), and the Max Delbrück Center (MDC) in Berlin. They were able to demonstrate why the architecture of healthy lymph nodes is altered in malignant lymphomas.https://www.gesundheitsindustrie-bw.de/en/article/press-release/influence-lymph-node-architecture-lymphoma
Press release - 24/03/2026 Ovarian Cancer: Adipose Tissue Influences the Efficacy of Immunotherapy In ovarian cancer, immunotherapies using checkpoint inhibitors have so far been effective in only a small number of patients. Researchers at the HI-TRON Mainz* have now discovered that lipid metabolism processes in the tumor microenvironment play a decisive role in how well such therapies work. The findings open up new avenues for using immunotherapies in a more targeted manner, increasing their effectiveness, and overcoming resistance.https://www.gesundheitsindustrie-bw.de/en/article/press-release/eierstockkrebs-fettgewebe-beeinflusst-wirksamkeit-der-immuntherapie
Press release - 23/03/2026 Aggravated neuroimmune response, delayed wound healing Transcription factor NF-κB in astrocytes critically affects the outcome of traumatic brain injury (TBI) Traumatic brain injuries often lead to complications with long-lasting consequences on memory, concentration and movement control. Detrimental secondary inflammatory reactions at the injured tissue sites are often responsible for this. Researchers from Ulm have now shown that a transcription factor plays a key role in reactions to TBI. When this gene regulator is activated, an elevated neuroimmune response promotes inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/aggravated-neuroimmune-response-delayed-wound-healing-transcription-factor-nf-kb-astrocytes-critically-affects-outcome-traumatic
Press release - 23/03/2026 New findings on the first steps in Protein Synthesis In the earliest phase of creating human proteins, the protein complex NAC performs an essential task by starting the first steps towards folding proteins into their correct three-dimensional structures. This discovery was made by an international research team led by scientists from the Center for Molecular Biology of Heidelberg University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-first-steps-protein-synthesis
Press release - 19/03/2026 New Approaches for Treatment-Resistant Disorders The German Center for Mental Health (DZPG) conducts nationwide research on individualized treatments for depression, anxiety disorders, and addiction. Its approach combines established therapeutic methods with innovative strategies to enhance overall treatment efficacy. The primary beneficiaries are patients for whom conventional therapies have so far proven insufficiently effective.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approaches-treatment-resistant-disorders
Press release - 19/03/2026 How old are we really? Ageing is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a method that uses biomarkers to determine a person's biological age – a valuable tool for research on ageing and the development of new approaches in preventive medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-old-are-we-really
Press release - 19/03/2026 Psilocybin combined with psychotherapy shows significant efficacy in treatment-resistant depression The results of the EPIsoDE study show that psilocybin can have a significant antidepressant effect. It is important that its use be integrated into psychotherapeutic pre- and post-treatment care. https://www.gesundheitsindustrie-bw.de/en/article/press-release/psilocybin-combined-psychotherapy-shows-significant-efficacy-treatment-resistant-depression
Press release - 12/03/2026 Brain Diseases: Certain Neurons Are Especially Susceptible to ALS and FTD Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms. Many patients have a common hallmark: A protein called TDP-43 clumps together in the neurons of the brain to form tiny lumps. Researchers at DZNE and Ulm University Hospital, together with international experts, have now discovered that these pathological changes primarily affect certain cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-diseases-certain-neurons-are-especially-susceptible-als-and-ftd
Press release - 10/03/2026 Advanced melanoma: Antibodies in the blood indicate side effects of immunotherapy Immunotherapies have greatly improved the treatment of metastatic melanoma, but they can cause serious side effects. A study led by researchers from Heidelberg University's Medical Faculty, the Heidelberg University Hospital, and the NCT in Heidelberg now shows that autoantibodies detected in the blood before the start of therapy could help to better assess the individual risk of side effects in patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/advanced-melanoma-antibodies-blood-indicate-side-effects-immunotherapy
Press release - 09/03/2026 Early detection contributes to declining breast cancer mortality rates in Europe The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the DKFZ. The most striking finding: after the introduction of screening, significantly more early-stage, less advanced tumors were detected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-detection-contributes-declining-breast-cancer-mortality-rates-europe
Press release - 02/03/2026 Novel therapy for Phelan-McDermid syndrome Drug development to be funded with up to 1.7 million euros An international team led by Professor Tobias M. Böckers from Ulm University Medical Centre has been awarded up to 1.7 million euros to develop a novel therapy for a rare, syndromic form of autism. The research project focuses on a gene whose loss of function can manifest itself in severe impairments in language, behaviour and everyday functions of those affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-therapy-phelan-mcdermid-syndrome-drug-development-be-funded-17-million-euros
Press release - 26/02/2026 Mitochondria influence lipid storage in cells The powerhouse of the cells, known as mitochondria, appear to be able to influence the number of lipid droplets in the cell. Research into this previously unknown mechanism was conducted using baker’s yeast. This is shown by a recent study by the University of Freiburg, the University of Bonn and the University Hospital Bonn and the University of Freiburg. The results have now been published in the journal Nature Cell Biology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mitochondria-influence-lipid-storage-cells
Press release - 25/02/2026 Magnetic Microrobot Swarms Enable Contactless Manipulation of Objects Through Fluidic Torque In a study, a team of researchers show that groups of magnetic microrobots can generate fluidic forces strong enough to rotate objects in different directions without touching them. These microrobot swarms can turn gear systems, rotate objects much larger than the robots themselves, assemble structures on their own, and even pull in or push away many small objects. The work was now published in Science Advances.https://www.gesundheitsindustrie-bw.de/en/article/press-release/magnetic-microrobot-swarms-enable-contactless-manipulation-objects-through-fluidic-torque
Press release - 19/02/2026 Seeing cells in a new light Illuminating the tiniest details of living cells just got a major boost: Scientists at the Max Planck Institute for Medical Research have developed new markers that glow in the far-red range and are activated by light. They are stable, easy to control, and compatible with several super-resolution microscopy techniques, as outlined in a paper published in the journal Chem.https://www.gesundheitsindustrie-bw.de/en/article/press-release/seeing-cells-new-light
Press release - 18/02/2026 New centre for cell research Technology impulse for the Lake Constance region: The new Single Cell Centre at the University of Konstanz offers technology and expertise to study cells individually and at high resolution – for applications in medical diagnostics, medication development and basic research at universities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-centre-cell-research
Press release - 18/02/2026 3D microtumors could revolutionize treatment decisions Chemotherapy is often a central component of treatment for advanced colorectal cancer. However, not every therapy is equally effective for every patient. Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* stem cell institute, and the biotech company Xilis in Utrecht, Netherlands, have now developed a new method for selecting the most effective drug before treatment begins. https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-microtumors-could-revolutionize-treatment-decisions
Press release - 18/02/2026 Shingles vaccination could slow cognitive decline New findings indicate that a shingles vaccination could not only reduce the risk of cognitive impairment and dementia, but also reduce disease progression among those living with dementia. https://www.gesundheitsindustrie-bw.de/en/article/press-release/shingles-vaccination-could-slow-cognitive-decline
Press release - 17/02/2026 Tracing Tumors in Cerebrospinal Fluid: A New Opportunity for Precision Diagnostics in Brain Tumors In a published scientific study, researchers have succeeded in accurately diagnosing common types of brain tumors in children and adolescents based on tumor-derived genetic material in cerebrospinal fluid. Until now, these so-called liquid biopsies were not capable enough for such reliable diagnostics. The international research team has therefore optimized a sequencing technique and developed an AI-based computational method. In a later step,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/tracing-tumors-cerebrospinal-fluid-new-opportunity-precision-diagnostics-brain-tumors
Press release - 13/02/2026 Molecular cause of radiation damage identified A severe side effect of radiation therapy can be debilitating fibrotic skin damage. Scientists at the German Cancer Research Center (DKFZ) have now identified a key factor in the development of this radiation damage. Modulating this factor could potentially prevent this severe adverse effect.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-cause-radiation-damage-identified
Press release - 13/02/2026 How pancreatic cancer prepares tumour environment Possible biomarker for earliest stage of development Even before a tumour in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which the carcinoma can grow. The scientists' study opens up new possibilities for developing personalised intervention strategies - before a difficult-to-treat tumour even develops.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-pancreatic-cancer-prepares-tumour-environment-possible-biomarker-earliest-stage-development
Press release - 11/02/2026 The scent of a loved one makes the heart beat faster A study by researchers at the University of Freiburg investigates how the scent of one’s partner influences stress reactions. The study participants showed that the subconsciously perceived scent of their respective partners increased their subjective perception of stress and caused their heart rate to rise, especially when the scent was perceived as sexually attractive.https://www.gesundheitsindustrie-bw.de/en/article/press-release/scent-loved-one-makes-heart-beat-faster
Press release - 10/02/2026 CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary Brain-Computer Interface system in a clinical trial. The implantation follows neurological gains observed in the study’s first participant. This represents another key milestone to evaluate CorTec’s fully implantable closed-loop BCI platform for therapeutic applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cortec-announces-successful-second-human-implantation-its-brain-computer-interface-bci-system
Press release - 04/02/2026 A double-edged sword: Chronic cellular stress promotes liver cancer - but at the same time renders tumors vulnerable to immunotherapy A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response to the tumor. This has now been published in the journal Nature by a team led by researchers from the DKFZ, the UKT, and the Sanford Burnham Prebys Medical Discovery Institute. However, the results also show that this very mechanism could help identify patients who respond particularly well to immunotherapy in the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/double-edged-sword-chronic-cellular-stress-promotes-liver-cancer-same-time-renders-tumors-vulnerable-immunotherapy
Press release - 27/01/2026 Using AI to Retrace the Evolution of Genetic Control Elements in the Brain Artificial intelligence allows tracing the evolution of genetic control elements in the developing mammalian cerebellum. An international research team led by biologists from Heidelberg University as well as the Vlaams Instituut voor Biotechnologie and KU Leuven has now developed advanced AI models that can predict the activity of these elements based solely on their DNA sequence. https://www.gesundheitsindustrie-bw.de/en/article/press-release/using-ai-retrace-evolution-genetic-control-elements-brain
Press release - 26/01/2026 AI learns from animals: New approach to improve surgical imaging Scientists at the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), and Mannheim University Medical Center (UMM) are presenting a method that enables artificial intelligence (AI) to learn how to transfer medical image data from animals to humans. This “xeno-learning” could help make surgical procedures safer and more precise in the future – without relying on human training data.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-learns-animals-new-approach-improve-surgical-imaging
Press release - 22/01/2026 NAKO study confirms link between smoking and depression A research group led by the Central Institute of Mental Health in Mannheim has confirmed for the first time within the German National Cohort an association between cigarette consumption and depression. The findings show that depression occurs more frequently over the lifetime of current and former smokers than among those who have never smoked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nako-study-confirms-link-between-smoking-and-depression
Press release - 22/01/2026 Knowledge Connector: better clinical decisions in molecular precision oncology Researchers at the National Center for Tumor Diseases (NCT) Heidelberg and the German Cancer Research Center (DKFZ) have developed a digital tool that significantly accelerates and improves clinical decisions in molecular precision oncology. The Knowledge Connector enables the structured and standardized evaluation of very extensive molecular tumor profiles and makes them available for personalized therapy decisions faster than before.https://www.gesundheitsindustrie-bw.de/en/article/press-release/knowledge-connector-better-clinical-decisions-molecular-precision-oncology
Press release - 20/01/2026 Spatial organisation of genetic material influences heart disease In a joint study conducted by the DZHK sites in Heidelberg, Munich and Göttingen, researchers are deciphering how the spatial organisation of the genome in the heart determines genetic disease risks.https://www.gesundheitsindustrie-bw.de/en/article/press-release/spatial-organisation-genetic-material-influences-heart-disease
Press release - 16/01/2026 How cells control inflammatory responses Inflammation has to work fast against pathogens—but it can't get out of control. Researchers at the German Cancer Research Center (DKFZ) have now deciphered in more detail how the organism masters this balancing act. Their work shows that cells use two different strategies to precisely control inflammatory genes and thus precisely regulate the inflammatory response.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-cells-control-inflammatory-responses
Press release - 08/01/2026 Award for EMG electrode research How modern medical technology can prevent serious consequences of surgical procedures is demonstrated by a recent internationally recognized scientific publication. The study “Validation of conductive resin as electrode material in neuromonitoring with 3D-printed probes” under the leadership of Drs. Kiese and Bucher was awarded at the ICST Conference in Japan and highlights a medical topic that is crucial for the quality of life of many people. https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-emg-electrode-research
Press release - 22/12/2025 Slow down to get ahead To ensure that protein production in our cells runs smoothly, the protein complex NAC slows down the rate of protein synthesis right at the start. An international research team with significant involvement of Konstanz biologists has now discovered what underlies this previously unknown function of NAC.https://www.gesundheitsindustrie-bw.de/en/article/press-release/slow-down-get-ahead
Press release - 17/12/2025 mRNA rejuvenates aging immune system - the liver as a fountain of youth Can the weakened immune systems of older individuals be rejuvenated? Researchers from the DKFZ, HI-STEM*, and the Broad Institute have demonstrated that this is possible with an innovative approach. In a study, the team showed that mRNA technology can be used to transform the liver in mice into a temporary source of important immune regulatory factors that are naturally lost during aging. https://www.gesundheitsindustrie-bw.de/en/article/press-release/mrna-rejuvenates-aging-immune-system-liver-fountain-youth
Press release - 16/12/2025 When partnership gets under your skin: How oxytocin and tenderness promote wound healing Tenderness can literally get under your skin: An international research group led by Heidelberg University's Medical Faculty and Heidelberg University Hospital has found that small skin wounds heal significantly faster in couples who are particularly affectionate with each other in everyday life and who also receive the hormone oxytocin. At the same time, they had lower stress levels. https://www.gesundheitsindustrie-bw.de/en/article/press-release/when-partnership-gets-under-your-skin-how-oxytocin-and-tenderness-promote-wound-healing
Press release - 16/12/2025 Hummingbird Diagnostics Publishes Study on RNA Biomarker Methylation in Liquid Biopsies Hummingbird Diagnostics GmbH, a pioneer in harnessing blood-based small RNAs for early disease detection and characterization, today announced the publication of a new study in Nature Communications Medicine introducing an Oxford Nanopore Technologies (ONT)-based method for detecting small RNA modifications in blood.https://www.gesundheitsindustrie-bw.de/en/article/hummingbird-diagnostics-publishes-study-rna-biomarker-methylation-liquid-biopsies
Press release - 08/12/2025 New mutation catalog facilitates personalized cancer therapy When gene mutations are found in the tumor of cancer patients, it is often unclear whether they promote tumor growth or whether a targeted therapy could be effective. A research team led by the Medical Center - University of Freiburg has now compiled a catalog in which over 11,000 gene variants of a central gene family were examined and evaluated for their role in tumor growth. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-mutation-catalog-facilitates-personalized-cancer-therapy
Press release - 28/11/2025 New RNA Class Discovered that Helps Keep Cells Organized Inside cells, RNAs and proteins form biomolecular condensates. These droplets are essential for organizing cellular life, yet why some RNAs cluster more readily than others has remained unclear. Disruptions in condensate formation are linked to developmental defects, cancer, and neurodegenerative diseases. Researchers at KIT have now identified a new class of RNA called smOOPs and gained a better understanding of how biomolecular condensates formhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/new-rna-class-discovered-helps-keep-cells-organized
Press release - 26/11/2025 Blood formation: Two systems with different competencies It has only recently become known that two parallel systems of blood formation exist in the body. Researchers at the DKFZ have developed a method to examine both systems separately in mice for the first time. Their surprising finding: the majority of immune cells do not originate from classic blood stem cells in the bone marrow, but from precursor cells that are independent of blood stem cells and are already present in the embryo. https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-formation-two-systems-different-competencies
Press release - 24/11/2025 Shield against metastases and genetically protected CAR-T cells: Double honor for Mirco Julian Friedrich Physician and cancer researcher Mirco Julian Friedrich from the German Cancer Research Center (DKFZ), the stem cell research institute HI-STEM*, and Heidelberg University Hospital (UKHD) has received two awards for two independent research projects: his novel approach to preventing liver metastases and his research on T cells, which he modifies to better protect them from attacks by natural killer cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/shield-against-metastases-and-genetically-protected-car-t-cells-double-honor-mirco-julian-friedrich
Press release - 21/11/2025 How mitochondria influence mental health Hans Kupczyk visiting professorship for Professor Martin Picard He researches stress and ageing at the interface of psychology and biology and is a guest at Ulm University: Professor Martin Picard from Columbia University has been awarded the Hans Kupczyk Visiting Professorship 2025, which is based in the Department of Clinical and Biological Psychology this year. On the occasion of the awarding of the visiting professorship, Picard spoke about energy as the foundation of human health of body and mind.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-mitochondria-influence-mental-health-hans-kupczyk-visiting-professorship-professor-martin-picard
Press release - 21/11/2025 Universität Heidelberg succeeds with three funding applications for Collaborative Research Centres Heidelberg University has been successful in the current approval round of the German Research Foundation (DFG) with three grant applications for major research consortia. In the life sciences and medicine, a Collaborative Research Centre working on the Wnt signaling pathway will enter its third funding period. Two transregional consortia with major participation by researchers from Ruperto Carola have also been extended. https://www.gesundheitsindustrie-bw.de/en/article/press-release/universitat-heidelberg-succeeds-three-funding-applications-collaborative-research-centres
Press release - 17/11/2025 How painkillers can contribute to anemia in cancer patients Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-painkillers-can-contribute-anemia-cancer-patients
Press release - 13/11/2025 Collaboration between KyooBe Tech and the German Center for Infection Research The technology company KyooBe Tech GmbH and the German Center for Infection Research (DZIF) have signed a memorandum of understanding to collaborate on future research and development projects. The aim of the collaboration is to evaluate an innovative technology for inactivating pathogens using the specific effect of low-energy accelerated electrons (Low Energy Electron Irradiation—LEEI) and to make it available to DZIF scientists.https://www.gesundheitsindustrie-bw.de/en/article/press-release/collaboration-between-kyoobe-tech-and-german-center-infection-research
Press release - 13/11/2025 Agile, lightweight, efficient, intelligent: Researchers are developing next-generation robots At the new Institute for Adaptive Mechanical Systems (IAMS) at the University of Stuttgart, the focus is on a new generation of walking robots and “soft robotics”. The researchers are developing adaptable robots inspired by natural movement patterns and made from innovative soft materials. The applications range from healthcare and industrial production to energy supply. https://www.gesundheitsindustrie-bw.de/en/article/press-release/agile-lightweight-efficient-intelligent-researchers-are-developing-next-generation-robots
Press release - 13/11/2025 Software optimizes simulations of the brain A new software enables brain simulations which both imitate the processes in the brain in detail and can solve challenging cognitive tasks. The program was developed by a research team at the Cluster of Excellence ‘Machine Learning: New Perspectives for Science’ at the University of Tübingen. The software thus forms the basis for a new generation of brain simulations which allow deeper insights into the functioning and performance of the brain.https://www.gesundheitsindustrie-bw.de/en/article/press-release/software-optimizes-simulations-brain
Press release - 07/11/2025 How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging. The scientist from the DKFZ-Hector Cancer Institute is the winner of the Falling Walls Foundation's “Breakthrough of the Year 2025” award in the Women's Impact category.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biological-clock-ticks-female-reproductive-tract-breakthrough-year-award-2025-angela-goncalves
Artificial intelligence: opportunities for healthcare - 06/11/2025 More than just deskwork: opportunities and obstacles for generative AI in healthcare Generative artificial intelligence (GenAI) has enormous potential in healthcare, ranging from automating time-consuming deskwork to supporting diagnoses. It is not just for the big players; there are also cost-effective ways for smaller companies and institutions to utilize GenAI.https://www.gesundheitsindustrie-bw.de/en/article/news/more-just-deskwork-opportunities-and-obstacles-generative-ai-healthcare
Press release - 29/10/2025 Replacing, reducing and refining animal testing Official launch of integrative 3R Centre at Ulm University Developing replacement methods for animal testing is the main goal of the 3R network. One of three new 3R centres in Baden-Württemberg was launched at Ulm University at the beginning of the year and has now officially started work with a kick-off event. The abbreviation 3R stands for "Replace, Reduce, Refine", i.e. replace and reduce animal testing and improve the conditions for unavoidable animal experiments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/replacing-reducing-and-refining-animal-testing-official-launch-integrative-3r-centre-ulm-university
Press release - 27/10/2025 Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The long-term goal is to develop new preventive strategies against colorectal cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/role-intestinal-bacteria-development-colorectal-cancer-emmy-noether-grant-dkfz-researcher-jens-puschhof
Press release - 24/10/2025 Freiburg coordinates national early warning system on animal influenza viruses Federal government awards 3.5 million euros in funding to the collaborative research project FLU-PREP. Researchers are developing methods to identify the pandemic potential of new viruses at an early stage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-coordinates-national-early-warning-system-animal-influenza-viruses
Press release - 16/10/2025 Sleep as the key to understanding ME/CFS The Federal Ministry of Research, Technology and Space (BMFTR) is supporting the “Sleep-Neuro-Path” research network with around 1.6 million euros. Coordinated by the Central Institute of Mental Health (CIMH) in Mannheim, a team of scientists is investigating the role of sleep-related biomarkers in the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleep-key-understanding-mecfs
Press release - 15/10/2025 NGS-based diagnostics for identifying sepsis pathogens wins EARTO Innovation Award A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patients to be identified much faster than before and with the highest precision. The approach is based on high-throughput sequencing of cell-free DNA circulating in the blood and was honored with the EARTO Innovation Award in the "Impact Delivered" category on October 14,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ngs-based-diagnostics-identifying-sepsis-pathogens-wins-earto-innovation-award
Press release - 10/10/2025 Acidic tumor environment promotes survival and growth of cancer cells Tumors are not a comfortable place to live: oxygen deficiency, nutrient scarcity, and the accumulation of sometimes harmful metabolic products constantly stress cancer cells. A research team from the DKFZ and the IMP in Vienna has now discovered that the acidic pH value in tumor tissue is a decisive factor in how pancreatic cancer cells adapt their energy metabolism in order to survive under these adverse conditions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/acidic-tumor-environment-promotes-survival-and-growth-cancer-cells
Press release - 10/10/2025 New tool offers single-cell study of specific genetic variants EMBL scientists created SDR-seq, a tool for single-cell DNA-RNA-sequencing that studies both DNA and RNA simultaneously, linking coding and non-coding genetic variants to gene expression in the same single cell. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tool-offers-single-cell-study-specific-genetic-variants
Press release - 09/10/2025 Transparent artificial intelligence improves assessment of prostate cancer aggressiveness Until today, the aggressiveness of prostate cancer has been assessed primarily using the Gleason grading system—an analysis of cancer tissue in a pathology laboratory that is highly subjective. An international research team led by the German Cancer Research Center (DKFZ) has now developed a novel, explainable AI model that aims to make the diagnosis of prostate cancer more transparent and less susceptible to error.https://www.gesundheitsindustrie-bw.de/en/article/press-release/transparent-artificial-intelligence-improves-assessment-prostate-cancer-aggressiveness
Press release - 09/10/2025 Another step towards a cure Vitamin A transporter reactivates latent HIV Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defence and antiviral drugs by becoming "latent". In this state, they are largely invisible and unassailable. As long as these dormant viruses persist, there is no cure for HIV/AIDS. However, researchers at Ulm University Hospital have discovered a new way to reactivate latent HI viruses. https://www.gesundheitsindustrie-bw.de/en/article/press-release/another-step-towards-cure-vitamin-transporter-reactivates-latent-hiv
Press release - 06/10/2025 3D imaging points to possible cause of sudden cardiac death An imaging technique developed by Freiburg researchers provides insights into cardiac arrhythmias that can cause sudden cardiac death in animal models. The changes discovered could explain why even seemingly healthy people are sometimes affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-imaging-points-possible-cause-sudden-cardiac-death
Press release - 29/09/2025 Actin scaffold in cell nucleus explains survival of cancer cells Researchers from the Cluster of Excellence CIBSS have demonstrated that an actin scaffold stabilizes the cell nucleus upon mechanical stress. This protective mechanism helps cancer cells to avoid dying during their migration in the body. In the long term, targeted interventions in this mechanism could help to prevent metastases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/actin-scaffold-cell-nucleus-explains-survival-cancer-cells
Press release - 24/09/2025 No GPS in the head: How the brain flexibly switches between internal maps Since their discovery in 2004, the grid cells in the brain, which are important for our orientation, have been regarded as a kind of “GPS in the head.” However, scientists at the DKFZ and Heidelberg University Hospital have now shown that grid cells work much more flexibly than previously assumed. In experiments with mice, the researchers found that the cells adapt their activity to different reference points depending on the situation. https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-gps-head-how-brain-flexibly-switches-between-internal-maps
Press release - 23/09/2025 Mutation in non-coding DNA worsens leukaemia prognosis Ulm study uncovers previously unknown disease-promoting mechanism Why is blood cancer particularly aggressive in some patients? Researchers at Ulm University Hospital have characterised a mutation in the so-called NOTCH1 gene that significantly influences the prognosis of chronic lymphocytic leukaemia (CLL). Remarkably, this mutation is located in the non-coding region of the gene – an area of DNA long considered less relevant for disease mechanisms.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mutation-non-coding-dna-worsens-leukaemia-prognosis-ulm-study-uncovers-previously-unknown-disease-promoting-mechanism
Press release - 23/09/2025 Institutional Partnership: Heidelberg and Harvard Sign Memorandum of Understanding On the basis of the cooperative relations that have developed over time, Heidelberg University and Harvard University are going to deepen and expand their cooperation. They have signed a Memorandum of Understanding to that effect. As an institutional internationalization project, the state of Baden-Württemberg is providing ten million euros to support this initiative, which is part of the state’s “Global Partnership in Science” activities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/institutional-partnership-heidelberg-and-harvard-sign-memorandum-understanding
Press release - 23/09/2025 Not all ALK fusions act the same: Variants influence treatment success in lung cancer About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all patients with these fusions the same way. However, new research led by scientists from the German Cancer Research Center (DKFZ) and Stanford University shows that not all fusion variants behave alike. https://www.gesundheitsindustrie-bw.de/en/article/press-release/not-all-alk-fusions-act-same-variants-influence-treatment-success-lung-cancer
Press release - 17/09/2025 Fat cells are the guardians of our health Researchers have discovered part of the answer to why some people with obesity or diabetes develop fatty liver disease while others remain healthier. They showed that fat cells have their own protective mechanism that prevents them from dying prematurely under stress. If this mechanism fails, the fat cells disintegrate. This can lead to tissue damage, inflammation and serious metabolic disorders.https://www.gesundheitsindustrie-bw.de/en/article/press-release/fat-cells-are-guardians-our-health
Press release - 16/09/2025 New CRISPR method leads to a better understanding of cell functions The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as “gene scissors”, which enables researchers to better understand how human cells function and stay healthy. Researchers at the University of Stuttgart have further developed CRISPR for this purpose. They present their CRISPRgenee method in Cell Reports Methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-crispr-method-leads-better-understanding-cell-functions
Press release - 15/09/2025 How HIV enters the genome – Researchers identify previously unknown mechanism Researchers at Heidelberg Uni Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids as molecular signposts for the virus. These findings reveal a vulnerability in the life cycle of HIV and provide therapeutic approaches for specifically controlling HIV reservoirs in the body. This has been one of the obstacles to curative HIV therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-hiv-enters-genome-researchers-identify-previously-unknown-mechanism
Press release - 12/09/2025 In bad company: Immune cells in the tumor environment determine the success of therapy for childhood brain tumors The cellular environment of a tumor can either support or sabotage recovery. The most comprehensive study to date on the tumor microenvironment in low-grade gliomas, conducted by KiTZ, Jena University Hospital, the DKFZ, and Heidelberg University Hospital, shows what a supportive or obstructive “neighborhood” looks like in childhood brain tumors. The study also provides clues as to how tumor communication might be blocked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bad-company-immune-cells-tumor-environment-determine-success-therapy-childhood-brain-tumors
Press release - 09/09/2025 Soft materials for smarter robots Soft robots, robot systems made of soft materials, open up new perspectives for medical technology and industry. Jun.-Prof. Dr. Aniket Pal from the University of Stuttgart is conducting research into viscoelastic materials that have the potential to embed intelligent functions in soft robots. He is receiving 1.5 million euros in funding for this research as part of the Emmy Noether Program. The funding period began on September 1, 2025.https://www.gesundheitsindustrie-bw.de/en/article/press-release/soft-materials-smarter-robots
Press release - 09/09/2025 Signals from the brain reveal what color a person is seeing Visual areas of the brain can reveal the colors a person is seeing while watching moving color rings. This was the result of a study by the University of Tübingen. Using MRI scanning they recorded images from the brains of subjects who were observing visual stimuli, and identified signals for red, green and yellow. The pattern of brain activity appeared similar in subjects, meaning that the color they saw could be predicted simply by comparison…https://www.gesundheitsindustrie-bw.de/en/article/press-release/signals-brain-reveal-what-color-person-seeing
Press release - 08/09/2025 New and simple detection method for nanoplastics A joint team from the University of Stuttgart in Germany and the University of Melbourne in Australia has developed a new method for the straightforward analysis of tiny nanoplastic particles in environmental samples. One needs only an ordinary optical microscope and a newly developed test strip—the optical sieve. The research results have now been published in “Nature Photonicshttps://www.gesundheitsindustrie-bw.de/en/article/press-release/new-and-simple-detection-method-nanoplastics
Press release - 05/09/2025 After EMBL: Umlaut.bio and its potential role in drug development Alumnus Bastian Linder discusses the origin of this start-up and how a tRNA mechanism is helping scientists understand the importance and use of various RNA modifications as they pertain to disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/after-embl-umlautbio-and-its-potential-role-drug-development
Press release - 04/09/2025 Rare bone tumors: Tailor-made mini-proteins switch off tumor drivers Chordomas are rare bone tumors for which there are no effective drugs. A research team from the DKFZ and the NCT Heidelberg has now developed a promising approach: Tailor-made mini-proteins specifically block the driver of tumor development. In the result, slowing the growth of chordoma cells in the laboratory and in a mouse model, while also revealing further molecular vulnerabilities of the tumor that could be addressed with approved drugs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/rare-bone-tumors-tailor-made-mini-proteins-switch-tumor-drivers-1
Press release - 03/09/2025 Nature publication: Mechanical tensions as a driver of evolution When embryos grow, cells and tissue are constantly bumping into each other. This creates mechanical tensions that could endanger their development. A team from University of Hohenheim and the Japanese RIKEN Center have discovered that fly embryos have strategies to deal with this pressure. The different species have developed two different solutions. This ability to control mechanical tension could be a key to why so many body plans have evolved.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nature-publication-mechanical-tensions-driver-evolution